Micron: Buy The China Panic

Micron fell from $1,097 after earnings to $953 amid a semiconductor selloff and news of CXMT's new DRAM cell design. Its 10-K values contracts at $134B in minimum prices, with $33.5B landing next year. The article argues that if FY27 and FY28 earnings are near consensus, $953 already prices in earnings reverting to roughly FY26 levels afterward—requiring an estimated 65% drop in memory prices.

Analysis

The key uncertainty is whether the reported contract floor meaningfully protects Micron’s consolidated earnings: minimum prices do not necessarily guarantee volumes, cover all product mix, or prevent spot-linked repricing elsewhere. Verify the contract scope, cancellation terms, and how much exposure is to commodity DRAM versus higher-value products before treating it as an earnings floor.

CXMT’s cell design is a medium-term supply risk, not by itself evidence of near-term incremental bit supply. The competitive threat becomes material only with demonstrated yields, capacity, and customer qualification; until then, the more immediate driver is industry pricing and the broader semiconductor risk-off move. If CXMT scales, pricing pressure could spill beyond Micron to Samsung Electronics and SK hynix, while potentially shifting customers’ sourcing decisions.

Near term, the sharp repricing raises squeeze risk if DRAM pricing and Micron guidance remain firm. Over 1–3 months, track contract/spot pricing, product mix, and guidance revisions. Over 6–18 months, monitor CXMT output and qualification for evidence that supply growth can overwhelm demand. The downside thesis is falsified by sustained pricing and upward earnings revisions; the recovery thesis is falsified by weakening realized prices, lower guidance, or verified CXMT volume ramp. Given the severe cycle-reset scenario apparently embedded in the shares, a fresh outright short has unattractive timing unless fundamentals confirm it.

Key Decisions for Investors

• Keep MU underweight versus diversified semiconductor exposure rather than add to an outright short here; reassess after the next pricing and guidance updates.
• For existing MU exposure, consider a defined-risk 3–6 month put spread only if DRAM pricing weakens or CXMT’s commercial ramp is independently verified; cap risk at the premium and avoid buying protection solely on the design announcement.
• Treat the contract value as a watch item, not a downside guarantee: verify minimum-volume obligations, duration, product coverage, and repricing clauses in filings or management disclosures.
• Upgrade the stance if realized pricing holds and earnings estimates move higher; cut exposure further if pricing weakens alongside downward guidance revisions or confirmed CXMT customer qualification and capacity.